C3i Center Inc
Louisa Petropoulos is CEO of C3i Center Inc, is a leading Canadian CDMO specialized in the development manufacturing cell & gene therapies. Louisa has a track record in developing and implementing innovative strategies leading to company sustainability and long term growth while maintaining its competitiveness. As part of the C3i mission of supporting and accelerating access to innovative cell & gene therapies C3i has invested and provided continued support to leading Canadian cell therapy companies.
Prior to C3i Louisa spent 20 years in biotechnology in business development, licensing and commercial roles that include C3i, Thrasos Therapeutics and publicly-listed company MethylGene (now Mirati). Louisa started her career and spent 8 years in venture capital as part of part of Innovatech du Grand Montreal and Multiple Capital Life Science Investment team, leading and supporting numerous deals and public offerings including Enobia and MethylGene (Mirati) leading to over $1B in value.